Skip to search formSkip to main contentSkip to account menu

PNU-100480

Known as: U-480 compound 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Oxazolidinones

Narrower (1)

sutezolid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches.
Tuberculosis is very much rampant in our society and accounts for a large number of deaths annually. In spite of consistent… 
Review
2015
Review
2015
Recent Advances in the Development of Anti-tuberculosis Drugs Acting on Multidrug-Resistant Strains: A review
Despite over a century of drug development research, tuberculosis remains a major public health problem with a leading cause of… 
2014
2014
IN VITRO ANTIMICROBIAL ACTIVITY OF BTZ043 AND PNU-100480 AGAINST MYCOBACTERIUM ULCERANS
Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected emerging tropical disease that is characterized by… 
2014
2014
In Vitro Antimicrobial Activity of BTZ043 and PNU-100480 Against Mycobacterium ulcerans
Review
2013
Review
2013
Meeting Report: World Tuberculosis Day Symposium 2012
Review
2012
Review
2012
Novel compounds and drugs and recent patents in treating multidrug-resistant and extensively drug-resistant tuberculosis.
A number of recent studies revealed that successful treatment of the patients with MDR/XDR- TB was not achieved due to high… 
Review
2011
Review
2011
Chapter 9:Current Approaches to Tuberculosis Drug Discovery and Development
Since the first streptomycin trials for TB in 1944, anti-TB drug discovery research has been inspired by the hope of developing a… 
2010
2010
Superbugs and Superdrugs-SMi's 12th annual conference--Overcoming resistance. 17-18 March 2010, London, UK.
  • A. Oni
  • IDrugs : the investigational drugs journal
  • 2010
  • Corpus ID: 37254210
The 12th Annual Superbugs and Superdrugs conference, held in London, included topics covering new therapeutic developments in the… 
Review
2010
Review
2010
Coalition to reduce development time of TB drug combinations
Coalition to reduce development time of TB drug combinations Nature Reviews Drug Discovery 9, 348–349 (2010) The news in brief… 
Review
2002
Review
2002
[Prospects for development of new antituberculous drugs].
  • H. Tomioka
  • Kekkaku : [Tuberculosis]
  • 2002
  • Corpus ID: 35766511
Tuberculosis (TB) is a growing international health concern, since it is the leading infectious cause of death in the world today… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)